Concepedia

Luhan Yang

LY

Statistics

Publications

4

Citations

126

H-Index

4

Active since

2022

Affiliations

Hangzhou DAC Biotech (China)(Current)

First Affiliated Hospital Zhejiang University

Zhejiang University

Luhan Yang is an author at Hangzhou DAC Biotech (China) specializing in immunotherapy, cell-based immunotherapy, and antitumor t cell responses.

ORCID

Publications per year

2022–2025

4

Publications

4

An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Xiaobing Wang, Yi Zhang, Yi Jin et al. · Cell · 2025 · 65 citations

, , +14

CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells

Linqin Wang, Yiyun Wang, Xiangjun He et al. · Cell Reports Medicine · 2025 · 39 citations · Full text

, , +15

Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus

Zezhong Zheng, Lei Xu, Yangbin Gao et al. · Microbiology Spectrum · 2024 · 12 citations · Full text

, , +17

Off-the-Shelf, Multiplexed-Engineered iPSC-Derived CD33 CAR-NK Cells for Treatment of Acute Myeloid Leukemia

Yiyun Wang, Linqin Wang, Mi Shao et al. · Blood · 2022 · 10 citations

, , +17

1–4 of 4